Rhumbline Advisers TELOMIR PHARMACEUTICALS Transaction History
Rhumbline Advisers
- $109 Billion
- Q3 2024
Number of Shares
4,176
Previous 5,062
17.5%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%